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Abstract
Purpose Prospective randomized trial to compare standard vs delayed approach to dorsal vascular complex (s-DVC vs 
d-DVC) in robot-assisted radical prostatectomy (RARP).
Methods Patients scheduled for RARP were randomized into a 1:1 ratio to receive either s-DVC or d-DVC by two experi-
enced surgeons. In s-DVC arm an eight-shaped single stitch was given at the beginning of the procedure and the DVC was 
subsequently cut at time of apical dissection; in d-DVC arm the plexus was transected at the end of prostatectomy, prior to 
apex dissection and then sutured. Primary endpoint was difference in estimated blood loss (EBL) and a sample size of 226 
cases was calculated; ad interim analysis was planned after 2/3 of recruitment.
Results Endpoint was reached at ad interim analysis after 162 cases (81 s-DVC, 81 d-DVC) and recruitment was, therefore, 
interrupted. Baseline and tumor characteristics were overlapping. EBL was significantly higher in d-DVC arm (mean EBL 
107 vs 65 ml, p = 0.003), but without differences in post-operative hemoglobin, transfusions and complications. Overall PSM 
rate was higher in d-DVC arm (21.0 vs 14.8%, p = 0.323), with statistical significance relatively to organ-confined disease 
(15.5 vs 3.6%, p = 0.031). Apical involvement was instead significantly higher in s-DVC arm (prevalence in PSM patients 
66.7 vs 23.5%, p = 0.020). Post-operative PSA, continence and potency rates were similar between groups.
Conclusions Standard and delayed approaches to DVC are safe and lead to similar functional outcomes. A delayed approach 
exposes to a higher risk of PSM in organ-confined disease but with a lower risk of apical involvement.
Keywords Dorsal vascular complex · Robot-assisted radical prostatectomy · Prostate cancer · Blood loss · Positive surgical 
margins
Introduction
The original description of open retropubic retrograde radi-
cal prostatectomy by Walsh and Lepor [1] prescribed to 
ligate the dorsal vascular complex (DVC) during the first 
steps of the procedure, immediately before to proceed for 
apical dissection. This maneuver aims at to control possible 
prohibitive bleeding that could worsen peri-operative course 
and impair both functional and oncological outcomes, given 
the strict anatomical relationships between DVC, prostatic 
apex, striated sphincter and neurovascular bundles [2].
Since a decade, robot-assisted radical prostatectomy 
(RARP) has challenged open prostatectomy as standard sur-
gical approach for prostate cancer, even if its superiority is 
still under debate [3–7]. Despite the anterograde—instead of 
retrograde—way of dissection robotics inherited from open 
prostatectomy the way to deal with the DVC: an early liga-
ture of DVC and its subsequent transection has indeed been 
generally considered as the standard approach to the DVC. 
However, it was postulated that suturing the plexus prior to 
apical dissection could tether the sphincter or prostatic tissue 
and render more challenging to develop the correct plan of 
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dissection during apical detachment. Consequently, various 
technical modifications of minimally-invasive radical pros-
tatectomy have been proposed counting on the hemostatic 
effect exerted by the intra-abdominal pressure given by the 
pneumoperitoneum [8, 9]. The most accepted alternative 
approach consists of the direct section of the DVC at the end 
of prostatectomy, going for suture afterwards: this sequence 
of steps is generally denominated delayed approach to the 
DVC.
The only available methodologically sound comparison 
between these two options has been published by Porpiglia 
and coll, that tested standard vs delayed approach in a ran-
domized fashion in purely laparoscopic radical prostatecto-
mies [10] showing an advantage on continence recovery for 
the latter. Nevertheless, the translation of these results to 
RARP is debatable because 3D vision and the intuitiveness 
and articulation of instruments should favor robotics, specifi-
cally in suturing. At least from a theoretically point of view, 
the better quality of sutures provided by robotic systems 
should be beneficial for both the approaches, either making 
preliminary stitch more selective or facilitating suturing after 
the transection of DVC.
During scientific meetings and live surgery events, an 
endless debate on the pro and contra of the different ways to 
manage DVC in RARP occurs, but this issue has been taken 
into account only by a few retrospective studies [11–13]. 
So, in the lack of high-quality evidence, these two alterna-
tives are chosen just on personal preferences and beliefs of 
surgeon.
Thus, we designed a prospective randomized controlled 
trial to compare standard (s-DVC) vs delayed approach to 
DVC (d-DVC) to assess differences in surgical, oncological 
and functional outcomes.
Materials and methods
Study design and population
A phase III prospective randomized controlled trial was 
designed in adherence to the CONSORT (CONsolidated 
Standards of Reporting Trials) guidelines [14] to compare 
standard (s-DVC group) with delayed (d-DVC group) liga-
tion of DVC. Authorization from the Institutional Review 
Board and Ethical Committee of Spedali Civili Hospital was 
obtained in August 2016 (approval number NP 2400) and 
registered at clinicaltrial.gov (identifier NCT03351088).
All consecutive patients scheduled for RARP were con-
sidered eligible. Inclusion criteria were patients aged 18 or 
older, willing and able to provide informed consent and his-
tological diagnosis of prostate cancer for whom radical pros-
tatectomy was indicated. Exclusion criteria were previous 
pelvic radiotherapy, impairment of coagulation or participa-
tion in other interventional trials.
Allocation concealment was ensured by the creation of 
a password-protected randomization database, generated 
by an automatic algorithm (http://www.rando mizer .org); 
randomization was done on a 1:1 ratio without stratifica-
tion. All information was registered into a dedicated data-
base. According to institutional policy anti-platelets agents 
were not suspended, while oral anticoagulation drugs were 
replaced by low-molecular weight heparin. A neoadjuvant 
course of androgen-deprivation therapy was administered 
at the discretion of the referring urologist. Comorbidities 
were summarized by the Charlson–Romano index [15] and 
American Society of Anesthesiology score [16]; operative 
time was calculated from skin incision to the closure of all 
wounds; estimated blood loss (EBL) was intended as the 
blood volume collected into the suctioning system. Lymph 
node dissection was indicated when the risk of lymph node 
invasion overcame 5% according to Briganti’s nomogram 
[17]. A nerve-sparing procedure was generally performed 
in low/intermediate-risk PCa according to D’Amico clas-
sification [18], bi- or unilaterally according to the risk of 
neurovascular invasion at each side as indicated by clinical 
framework or intra-operative view. A drainage was regularly 
put and removed when clinically indicated, generally at the 
recovery of bowel canalization; the catheter was generally 
maintained for 7 days, and removed without cystogram, if 
not clinically indicated. 30-day complications were pro-
spectively recorded in according to Clavien–Dindo grad-
ing system through face-to-face interview with a medical 
doctor [19, 20]. All specimens were evaluated by an expert 
uropathologist (SF) following International Society of Uro-
pathologist recommendations [21]. Positive surgical mar-
gins (PSM) were defined as the presence of cancer cells 
on the inked surface of prostate and sites of positivity were 
detailed. Follow-up controls were done at a dedicated outpa-
tient office, according to internal schedule (visit and PSA at 
1, 3 and 6 months for 2 years, and then yearly) and included 
the administration of validated questionnaires, as The 
Expanded Prostate Cancer Index Composite (EPIC) [22].
Surgical technique
Robotics was introduced at our institution since 2010 with 
the acquisition of a four-arm  DaVinci® Si system (Intui-
tive Surgical, Inc. Sunnyvale, CA, USA) and nowadays it is 
our exclusive approach for radical prostatectomy. Two sur-
geons performed all robotic procedures and at the time of the 
study achieved equivalent experience of around 350 RARP. 
The procedure was done through a transperitoneal antero-
grade approach, broadly following the technique of Patel 
and coll [23]. A so-called “urethral sparing” was generally 
attempted during apical dissection, unless the risk of cancer 
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involvement was deemed as significant, due to positive biop-
sies and/or clinical, radiological or intra-operative suspicion. 
For all the procedures, thermal energy was applied by pin-
point application of low-intensity (25 W) mono-polar cau-
tery and omitted, as much as possible, during neurovascular 
and apical dissection. Non-readsorbable clips (Hem-o-lok® 
ligation system, Weck, Teleflex, USA) were used only on 
prostatic pedicles.
Per protocol, in the standard ligation arm (s-DVC), after 
opening the endopelvic fascia, the lateral aspects of prostate 
were dissected and the DVC isolated and sutured by a 1 –0 
monofilament suture with a 1/2 circle 40-mm needle, avoid-
ing to throttle the pubo-prostatic ligaments (Fig. 1).
In the delayed ligation arm (d-DVC), the DVC was ther-
mally incised immediately before apex dissection; once pros-
tate detachment was completed, a vertical running suture 
with 3 − 0 monofilament on a 5/8 circle 26-mm needle was 
done, side-to-side, right to left (Fig. 2); in case of bleeding 
intra-abdominal pressure was increased up to 15–18 mmHg 
and suction by the assistant discouraged.
Endpoints
The primary endpoint was estimated blood loss (EBL): this 
choice aimed at to warrant the feasibility and reproducibility 
of the study, both in statistical and clinical terms. Indeed 
the few existing literature on the outcomes of s- vs d-DVC 
approaches for RARP reports consistent results only with 
regard to EBL. Moreover, the planned difference between 
arms based on EBL allowed a sample size affordable for the 
case load of our institution. Other outcomes of prominent 
clinical interest were instead adopted as secondary endpoints 
and were overall and apical positive surgical margins (PSM), 
1-month PSA value, and continence and potency rates. In 
particular, continence was defined as “no need for pads” or 
“1 security pad/day” (EPIC question number 5 “How many 
pads or adult diapers per day did you usually use to control 
leakage during the last 4 weeks?” [22]), while potency as 
the ability to achieve intercourse spontaneously or with oral 
drugs.
Sample size definition
In our previous experience with s-DVC approach a mean 
EBL of 54.0 ml (standard deviation, SD ± 75.3 ml) was 
observed. The few published studies on this issue [11–13] 
reported that d-DVC approach determined a positive differ-
ence in EBL, ranging from 10 to 100 ml. Therefore, for the 
present trial we arbitrarily set a difference of 30 ml as signif-
icant, because equal to a relative increase > 50% with respect 
to our historical data and within the range reported by the 
literature. Considering an expected EBL of 54.0 ± 75.3 ml 
for s-DVC, and a difference of 30 ml in d-DVC, the sample 
size—estimated by log-rank test of equal proportions with 
an α of 0.05 and a power of 85%—was 226 cases, 113 for 
each arm. An ad interim analysis was planned at two-third 
of enrollment, namely 150 patients.
Fig. 1  Standard ligation of DVC: after opening the endopelvic fascia 
and lateral dissection of prostate up to the apex, a eight-figure 1 − 0 
CT-1 stitch was given, without including pubo-prostatic ligaments; 
transection of the DVC was postponed at the end of prostatectomy 
before the section of the urethra
Fig. 2  Delayed ligation of 
DVC: at the end of prostatec-
tomy, prior to apex dissection, 
the DVC was transected; once 
completed the detachment of 
prostate, a vertical running 
suture with 3 − 0 UR-6 needle, 
side-to-side, right to left, was 
given
 Journal of Robotic Surgery
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Statistical analysis
Variables were reported as median ± standard deviation 
(SD) for parametric distribution, median and interquar-
tile range (IQR) for non-parametric, numbers and propor-
tions for categorical variables. Differences were compared 
using the Student t-test, Mann–Whitney u-test, Pearson 
chi-square or Fisher exact test, as appropriate. Data were 
analyzed according to a per protocol principle, including 
only patients in whom no protocol violation occurred. Dif-
ferences were considered significant for p < 0.05; all tests 
were two sided. Analysis was performed with Stata soft-
ware v14.0 (StataCorp LLC, TXS, USA).
Results
Baseline features
From August 2016 to December 2017, 162 patients were 
enrolled and randomized for s-DVC (81 patients) vs d-DVC 
arms (81 patients). At the time of planned ad interim analy-
sis, the difference in EBL between arms was statistically 
significant (s-DVC vs d-DVC, mean EBL 65 vs 107 ml, 
p = 0.003, difference 42 ml), so that enrollment was sus-
pended and the analysis finalized.
Baseline features of both groups were overlapping, in 
particular regarding the clinical and bioptic features of PCa 
(Table 1).
Table 1  Baseline features of 
cohort
SD standard deviation, BMI Body Mass Index, IQR interquartile range, ASA American Society of Anes-
thesiology, TURP transurethral resection of the prostate, PSA prostate-specific antigen, ISUP international 
society of uropathologist
s-DVC d-DVC p value
Age (years), mean (± SD) 64.2 (± 6.4) 65.0 (± 6.4) 0.385
BMI (kg/m2), mean (± SD) 26.4 (± 3.6) 26.4 (± 3.5) 0.991
Charlson Comorbidity Index, median (IQR) 0 (0–1) 0 (0–1) 0.567
ASA score, median (IQR) 2 (2–2) 2 (2–2) 0.929
Antiplatelet/Anticoagulant therapy, number (%) 14 (17.3%) 17 (21.2%) 0.523
Previous TURP, number (%) 3 (3.7%) 3 (3.7%) 1.000
Alfa-blockers, number (%) 19 (23.5%) 17 (21.0%) 0.705
5-alfa reductase inhibitors, number (%) 5 (6.2%) 5 (6.2%) 1.000
Positive digital rectal examination, number (%) 16 (19.7%) 24 (29.6%) 0.145
TRUS prostate volume (cc), mean (± SD) 48.9 ± 24.5 48.3 ± 27.2 0.879
Pre-operative PSA (ng/mL), mean (± SD) 9.1 (± 13.1) 8.2 (± 5.7) 0.594
Positive cores (number), median (IQR) 3 (2–5) 4 (2–6) 0.366
Core’s involvement (%), mean (± SD)
 Mean involvement 22.2 ± 17.5 27.0 ± 20.1 0.254
 Maximum involvement 36.0 ± 28.7 43.1 ± 28.8 0.134
Clinical stage, number (%) 0.941
 cT1 64 (79.0%) 60 (74.1%)
 cT2 15 (18.5%) 19 (23.4%)
 cT3 2 (2.5%) 2 (2.5%)
Biopsy ISUP group, number (%) 0.586
 1 38 (47.0%) 41 (50.5%)
 2 22 (27.2%) 18 (22.2%)
 3 10 (12.2%) 14 (17.3%)
 4 7 (8.6%) 4 (5.0%)
 5 4 (5.0%) 4 (5.0%)
D’Amico risk class, number (%) 0.596
 Low risk 32 (39.5%) 35 (43.2%)
 Intermediate risk 38 (46.9%) 39 (48.1%)
 High risk 11 (13.6%) 7 (8.6%)
 Neoadjuvant androgen-deprivation therapy, number (%) 18 (22.2%) 18 (22.2%) 1.000
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Intra‑operative data and peri‑operative outcomes
Groups were balanced concerning surgeon, lymphadenec-
tomy, nerve-sparing dissection and operative time. As 
above reported a significant difference was found in EBL, 
although post-operative decrease in hemoglobin value was 
similar (− 1.5 g/dl for each arm), as well as for the days 
of drainage and catheter, transfusions (1 event in d-DVC 
group) and complications in general (1 ureteral lesion Cla-
vien–Dindo 3b, requiring robotic reimplantation in 14th 
post-operative day in d-DVC group) (Table 2).
Oncological outcomes
The characteristics of PCa at final pathology were equiv-
alent between groups regarding tumor volume, local 
staging, lymph node invasion and grading. Also overall 
PSM rate was similar (d-DVC vs s-DVC 21.0 vs 14.8%, 
p = 0.323), but subgroup analysis showed a significant 
higher PSM rate for the d-DVC group in case of pT2 dis-
ease (15.5 vs 3.6%, p = 0.031). The topography of the sites 
of PSM was similar, except for the location at the apex that 
was significantly more frequent in the s-DVC group, repre-
senting 66.7 vs 23.5% of PSMs (p = 0.020). Post-operative 
PSA at 1, 3 and 6 months was available for 162, 116 and 
82 patients, respectively, and was similar between s-DVC 
and d-DVC groups (Table 3). Only four patients (one in 
s-DVC vs three in d-DVC, p not significant) experienced 
a biochemical relapse.
Functional outcomes
Continence was assessed at 1, 3 and 6 months finding similar 
rates between s-DVC and d-DVC, equal to 81.5 vs 76.5% 
(p = 0.440), 95.0 vs 91.4% (p = 0.393) and 97.0 vs 98.0% 
(p = 0.752), respectively. Using the definition “no pads” 
these figures declined to 39.5 vs 40.7% (p = 0.873), 63.3 vs 
60.0% (p = 0.680) and 73.1 vs 77.5% (p = 0.587). Also the 
potency rate, evaluated in 88 patients submitted to a nerve-
sparing procedure, was similar between s-DVC and d-DVC 
and equal to 28.3 vs 21.4% (p = 0.460) at 1 month, 37.8 vs 
31.6% (p = 0.555) at 3 months and 50.0 vs 44.8% (p = 0.668) 
at 6 months.
Discussion
The present trial aims at giving evidence useful to shed light 
on the debate on which is the preferential approach to the 
DVC during RARP. In summary, the main findings are: (1) 
intra- and peri-operative courses overlapped and this cor-
roborates the safety of the delayed approach; (2) the recov-
ery of continence and potency occurred at similar times 
and magnitude, confuting the advantages advocated for the 
delayed approach; (3) incidence and topographic distribution 
of PSMs were different, with higher PSM rate in pT2 cancer, 
but also a lower prevalence of apex involvement in d-DVC.
Despite the randomized and prospective design of the 
present study, these findings deserve a careful and in-depth 
critical discussion. Unfortunately, the room for a comparison 
Table 2  Intra-operative features 
and peri-operative outcomes
SD standard deviation, POD post-operative day
s-DVC d-DVC p value
First surgeon, number of procedures (%) 0.875
 1 39 (48.1%) 40 (49.3%)
 2 42 (51.8%) 41 (50.6%)
Lymph node dissection, number (%) 32 (39.5%) 34 (42.0%) 0.749
Nerve-sparing procedure, number (%) 46 (56.8%) 42 (51.8%) 0.528
Bilateral nerve-sparing procedure, number (%) 31 (38.2%) 27 (33.3%) 0.888
Operative time (minutes), mean (± SD) 205.6 (± 37.2) 200.2 (± 39.2) 0.398
Estimated blood loss (mL), mean (± SD) 65.0 (± 96.6) 107.1 (± 134.2) 0.003
Post-operative transfusion, number (%) 0 (0%) 1 (1.2%) 0.313
Delta pre-operative/3rd POD Hb (g/dl), mean (± SD) − 1.5 (± 1.4) − 1.5 (± 1.1) 0.787
Clavien–Dindo post-operative complications, number (%) 0.428
 0 79 (97.5%) 75 (92.6%)
 1 2 (2.5%) 4 (5.0%)
 2 0 (0%) 1 (1.2%)
 3b 0 (0%) 1 (1.2%)
Days of drainage, median (IQR) 3 (2–4) 3 (2–3) 0.299
Day of feeding, median (IQR) 2 (1–2) 2 (1–2) 0.878
Days of catheter, median (IQR) 7 (6–7) 7 (7–7) 0.174
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with the existing literature is fairly limited, since the only 
available randomized trial on DVC management enrolled a 
lower number of cases (30 vs 30 cases), involved one single 
expert surgeon, and dealt with purely laparoscopic prosta-
tectomy [10]. Thus, given the technical differences between 
laparoscopy and robotics the major finding—an advantage 
on early continence recovery for d-DVC—cannot be directly 
translated to our setting. Also the literature specifically deal-
ing with this issue of DVC management in robotics is poor 
and restricted to three retrospective comparative studies, 
with single-surgeon cohorts in size comparable to ours: Lei 
and coll [11] compared 303 s-DVC and 240 d-DVC, Woldu 
and coll [12] 118 s-DVC and 126 d-DVC and Otsuki and 
coll [13] 115 s-DVC and 62 d-DVC. The results on mor-
bidity were consistent among all the studies and confirmed 
the safety of a delayed approach: a higher EBL in d-DVC 
group was uniformly reported, generally reaching statistical 
significance [11, 13], but no difference was noted in clini-
cal course, transfusion and complication rates. Functional 
outcomes were similar, too: except for the study from Lei 
and coll [11] that found a difference in the 6-month conti-
nence rate, higher for d-DVC approach (61.4 vs 39.6%, defi-
nition 0 pad/day), no differences in continence or potency 
recovery were observed, at any time point. These results, 
on the whole, confute the assumption that an early standard 
approach could negatively influence functional recovery 
due to a damage to the sphincter or neurovascular bundles. 
This hypothesis, claimed considering that the ventral and 
more prominent portion of the striated sphincter could be 
entrapped by an inappropriate suture of the DVC [2, 24], 
probably should be renegotiated for robotic surgery. Indeed 
only studies on purely laparoscopic prostatectomy showed 
worse early continence rates for the standard approach [10, 
25, 26], probably in virtue of a less accurate suture.
Table 3  Pathological findings and oncological outcomes
s-DVC d-DVC p value
Pathological T stage, number (%) 0.643
 pT2a 7 (8.6%) 8 (9.9%)
 pT2b 4 (4.9%) 1 (1.2%)
 pT2c 46 (56.8%) 49 (60.5%)
 pT3a 19 (23.5%) 15 (18.5%)
 pT3b 2 (2.5%) 5 (6.2%)
 pN+ 3 (3.7%) 3 (3.7%)
Pathological ISUP group, number (%) 0.426
 1 32 (39.5%) 28 (34.6%)
 2 16 (19.7%) 22 (27.2%)
 3 11 (13.6%) 11 (13.6%)
 4 5 (6.2%) 1 (1.2%)
 5 9 (11.1%) 9 (11.1%)
 Not assessable 8 (9.9%) 10 (12.3%)
Tumor volume (% on whole gland), median (IQR) 8 (5–15) 8 (5–16) 0.902
PSM analysis
 PSM overall, number (% on 162 patients) 12 (14.8%) 17 (21.0%) 0.323
 PSM < pT3, number (% on 115 patients) 2 (3.6%) 9 (15.5%) 0.031
 PSM ≥ pT3, number (% on 47 patients) 10 (41.7%) 8 (34.8%) 0.393
 PSM nerve-sparing procedure, number (% on 88 patients) 5 (10.9%) 7 (16.7%) 0.429
 Multifocal PSM, number (% out of 29 patients with PSM) 6 (50.0%) 9 (53.0%) 0.876
Site of PSM, number (% out of 29 patients with PSM)
 Apical 8 (66.7%) 4 (23.5%) 0.020
 Posterior 8 (66.7%) 10 (58.8%) 0.668
 Lateral 2 (16.7%) 5 (29.4%) 0.430
 Anterior 3 (25.0%) 5 (29.4%) 0.793
 Base 1 (8.3%) 2 (11.8%) 0.765
Post-operative PSA (ng/mL), median (IQR)
 1 month 0.015 (0.01–0.04) 0.02 (0.01.0.05) 0.484
 3 months 0.01 (0.01–0.04) 0.018 (0.005–0.04) 0.913
 6 months 0.01 (0.01–0.04) 0.021 (0.01–0.04) 0.378
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The more debatable finding of our study concerns the 
data on PSM, also considering the inconsistency with 
other published data. Indeed, Lei [11] found no differ-
ences in overall and apical PSM rates, Woldu [12] found 
no differences in apical PSM and Otsuki [13] found a sig-
nificant higher overall PSM in d-DVC (26.1 vs 11.3%), 
but similar involvement of the apex. First of all, we must 
acknowledge that the design of our trial was not powered 
to detect differences in PSM rate and, therefore, no defini-
tive conclusions should be reached on this. At the same 
time, it should be remarked that the randomized and pro-
spective design probably mitigated biases, by generating 
two groups with equal clinical, surgical and pathological 
features. Therefore, the conclusions we reached were rea-
sonably at least more solid than other studies. To attempt 
at a cautious explanation of our findings, we can hypoth-
esize that the lower PSM rate in pT2 PCa for the s-DVC 
group could be related to a reduction in venous back-flow 
that aided the dissection from bladder neck to the apex. On 
the other hand, the differences in the prevalence of apical 
margins could be due to an improved precision during api-
cal dissection given by the higher mobility of prostate in 
case of delayed ligation of the DVC. Even if such consid-
erations require to be confirmed by larger series to balance 
the possible effects due to chance, they could constitute 
the base on which to tailor surgical strategy according to 
the localization of PCa at pre-operative framework. In par-
ticular, the d-DVC could be preferred in case of suspicious 
apical involvement, whereas the s-DVC when PCa involves 
other sites of the gland. Despite the lack of advantages at 
randomized comparison, at now our preference is reserved 
to a delayed modified approach, suturing the DVC after its 
section but before apical dissection and urethral detach-
ment, to favor a selective ligature.
Finally, we believe that our results could be reproduced 
at the majority of institutions due to the involvement of two 
different surgeons with not extensive, even well established, 
experience and not of a single highly experienced surgeon.
The major limitation of the study is related to the estima-
tion of sample size on EBL. So that, our findings on positive 
margins, continence and potency should be considered less 
definitive.
Conclusion
The results from the present trial suggest that both standard 
and delayed approaches to the DVC in RARP are safe with 
equal functional outcomes. The standard approach seems 
to expose to a lower risk of PSM in organ-confined disease 
at all sites, whereas the delayed approach should benefit a 
lower risk of positive apical margins.
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